Cargando…
Antitumor activity of a novel oral signal transducer and activator of transcription 3 inhibitor YHO‐1701
The signal transducer and activator of transcription 3 (STAT3) signaling pathway is a key mediator of cancer cell proliferation, survival and invasion. Aberrant STAT3 has been demonstrated in various malignant cancers. YHO‐1701 is a novel quinolinecarboxamide derivative generated from STX‐0119. Here...
Autores principales: | Nishisaka, Fukiko, Taniguchi, Keisuke, Tsugane, Momomi, Hirata, Genya, Takagi, Akimitsu, Asakawa, Naoyuki, Kurita, Akinobu, Takahashi, Hiroyuki, Ogo, Naohisa, Shishido, Yoshiyuki, Asai, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226286/ https://www.ncbi.nlm.nih.gov/pubmed/32112605 http://dx.doi.org/10.1111/cas.14369 |
Ejemplares similares
-
Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell lines
por: Taniguchi, Keisuke, et al.
Publicado: (2021) -
Perifosine, a Bioavailable Alkylphospholipid Akt Inhibitor, Exhibits Antitumor Activity in Murine Models of Cancer Brain Metastasis Through Favorable Tumor Exposure
por: Taniguchi, Keisuke, et al.
Publicado: (2021) -
YPC‐21661 and YPC‐22026, novel small molecules, inhibit ZNF143 activity in vitro and in vivo
por: Haibara, Hirotaka, et al.
Publicado: (2017) -
Sequential Pressure-Induced B1–B2 Transitions in the Anion-Ordered Oxyhydride Ba(2)YHO(3)
por: Morgan, Harry W. T., et al.
Publicado: (2022) -
Crespones y campanas tlaxcaltecas en 1701 /
por: González Acosta, Alejandro
Publicado: (2000)